A detailed history of Hudson Valley Investment Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 10,594 shares of ABT stock, worth $1.26 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,594
Previous 10,819 2.08%
Holding current value
$1.26 Million
Previous $1.12 Million 7.38%
% of portfolio
0.13%
Previous 0.14%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$100.07 - $118.13 $22,515 - $26,579
-225 Reduced 2.08%
10,594 $1.21 Million
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $57,451 - $70,324
-637 Reduced 5.56%
10,819 $1.19 Million
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $7,164 - $8,596
-75 Reduced 0.65%
11,456 $1.11 Million
Q2 2023

Jul 17, 2023

SELL
$100.78 - $112.29 $24,791 - $27,623
-246 Reduced 2.09%
11,531 $1.26 Million
Q1 2023

Apr 06, 2023

SELL
$96.86 - $114.01 $31,479 - $37,053
-325 Reduced 2.69%
11,777 $1.19 Million
Q4 2022

Jan 31, 2023

SELL
$95.06 - $111.52 $9,506 - $11,152
-100 Reduced 0.82%
12,102 $1.33 Million
Q3 2022

Oct 11, 2022

SELL
$96.76 - $112.03 $20,222 - $23,414
-209 Reduced 1.68%
12,202 $1.18 Million
Q2 2022

Jul 18, 2022

BUY
$102.07 - $123.37 $21,740 - $26,277
213 Added 1.75%
12,411 $1.35 Million
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $197,272 - $218,240
-1,691 Reduced 12.18%
12,198 $1.44 Million
Q2 2021

Jul 07, 2021

SELL
$105.79 - $124.53 $79,765 - $93,895
-754 Reduced 5.15%
13,889 $1.61 Million
Q1 2021

Apr 23, 2021

SELL
$108.84 - $128.23 $24,489 - $28,851
-225 Reduced 1.51%
14,643 $1.76 Million
Q4 2020

Jan 15, 2021

SELL
$105.0 - $114.42 $45,675 - $49,772
-435 Reduced 2.84%
14,868 $1.63 Million
Q3 2020

Oct 13, 2020

SELL
$91.64 - $111.29 $169,075 - $205,330
-1,845 Reduced 10.76%
15,303 $1.67 Million
Q2 2020

Jul 07, 2020

SELL
$76.57 - $98.0 $103,369 - $132,300
-1,350 Reduced 7.3%
17,148 $1.57 Million
Q1 2020

Apr 29, 2020

SELL
$62.82 - $91.86 $185,507 - $271,262
-2,953 Reduced 13.77%
18,498 $1.46 Million
Q2 2019

Jul 16, 2019

SELL
$72.88 - $85.0 $3,644 - $4,250
-50 Reduced 0.23%
21,451 $1.8 Million
Q1 2019

Apr 10, 2019

SELL
$66.22 - $80.06 $104,296 - $126,094
-1,575 Reduced 6.83%
21,501 $1.72 Million
Q4 2018

Jan 17, 2019

BUY
$65.56 - $74.27 $13,112 - $14,854
200 Added 0.87%
23,076 $1.67 Million
Q2 2018

Jul 10, 2018

SELL
$57.57 - $63.54 $72,653 - $80,187
-1,262 Reduced 5.23%
22,876 $1.4 Million
Q1 2018

Apr 12, 2018

BUY
$56.27 - $63.62 $4,220 - $4,771
75 Added 0.31%
24,138 $1.45 Million
Q4 2017

Jan 16, 2018

SELL
$53.68 - $57.47 $13,956 - $14,942
-260 Reduced 1.07%
24,063 $1.37 Million
Q3 2017

Oct 13, 2017

BUY
$48.06 - $53.64 $1.17 Million - $1.3 Million
24,323
24,323 $1.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hudson Valley Investment Advisors Inc Portfolio

Follow Hudson Valley Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.